News/Event

Our strength

EPS International Co. Ltd (EPS INTERNATIONAL) a subsidiary of a public listed company EPS Co. Ltd (EPS) in Tokyo, Japan, commences its business operations in April 2007.
EPS INTERNATIONAL aims to provide a seamless clinical research and development platform through strategizing and synergizing its established research networks, valuable knowledge, know-how, resources and experiences in Asia region. EPS INTERNATIONAL is fully supported by a team of high caliber, diligent and dedicated clinical professionals having many years of experiences in managing large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices.

A correlative figure

EPS INTERNATIONAL is fully supported by a team of high caliber, diligent and dedicated clinical professionals having many years of experiences in managing large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices.

Regulatory Expertise

Mastering in diverse regulatory requirements especially in Japan, China, Korea, Taiwan and other Asian countries enabling us to accurately forecast and manage overall project timelines for drug development and product commercialization

Relationship Expertise

Established high level and strong relationships with leading clinical investigators and research therapeutic networks in key Asian countries enabling us to expedite study start-up, patient recruitment and study completion

Team Expertise

Having multilingual elite clinical professionals with combined clinical trial experiences in managing either global-Japanese or global-Asian studies enabling us to provide global standards supplemented with local practices facilitating effectiveness in clinical trial and project management to meet various expected standards of the regulatory authorities

Resource Expertise

Leveraging integrated processes and resources within EPS Group enabling us to provide one-stop multi-service integration and implementation for research, development and commercialization for drugs and medical devices worldwide through utilizing advanced information technology and management platform

Therapeutic Expertise

Demonstrated therapeutic expertise are Oncology, Cardiovascular, Endocrine/Metabolism, Central Nervous System, Gastroenterology, Infectious Disease and Vaccines (Preventive and Therapeutic) enabling us to offer broad study experience and direct knowledge of study requirements. Other important therapeutic areas include:

  • Allergy/Immunology
  • Anesthesia
  • Dermatology
  • Genitourinary
  • Hematology
  • Obstetrics/Gynecology
  • Ophthalmology
  • Orthopedics
  • Otolaryngology
  • Pediatrics
  • Psychiatry
  • Respiratory
  • Rheumatology

At EPS INTERNATIONAL, we understand that our global and Japanese customers have particular needs and expectations in their global and Japan-Asian drug development programs. We also realize the importance of delivering and exceeding these needs and expectations. In line with its parent company's unique and industry recognized standards of service values, EPS INTERNATIONAL is committed to devote its utmost efforts and contributions in accelerating drug development process, maximizing return on investment whilst containing development costs and risks in each and every project for its valued customers.

EPS foreign countries network
  • Brochure PDF DOWNLOAD